Top compounds associated with response to GNA13


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.16 0.0004
mRNA prima-1 CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.11 0.0005
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA Bortezomib gCSI pan-cancer AAC -0.22 0.0008
Download CSV